OncoDNA teams up with SOPHiA GENETICS to Enable Laboratories to Establish Data-Driven Medicine as a Standard of Care

October 1st 2021


OncoDNA, a genomic and theranostic company specializing in precision medicine for the treatment of patients with cancer and genetic diseases, and SOPHiA GENETICS S.A., a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research, announced today an agreement facilitating the analysis and interpretation of genomic profiling.

Read Pdf